Berg Victoria, Lollies Anna, Schneider Markus, Johansson Patricia, Weniger Marc A, Albertini Emma, Facchetti Fabio, Ascani Stefano, Moawia Abubakar, Bens Susanne, Fischer Anja, Siebert Reiner, Klapper Wolfram, Lorenzi Luisa, Tiacci Enrico, Hartmann Sylvia, Budeus Bettina, Hansmann Martin-Leo, Küppers Ralf
Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Gilead Science GmbH, Martinsried/Munich, Germany.
Leukemia. 2025 May 22. doi: 10.1038/s41375-025-02549-y.
When two lymphomas occur concurrently or sequentially in a patient, it is a major question whether they derive from the same lymphocyte or hematopoietic precursor cell or developed independently. We studied four composite classic Hodgkin lymphomas (HL) and other mature B-cell lymphomas, and two composite mature B- and T-cell neoplasias by whole exome sequencing (WES). Analysis of their IGV genes revealed that three composite B-cell lymphomas originated from common germinal center-experienced B cells. WES identified shared somatic mutations in the lymphomas of these clonally related composite lymphomas, indicating their derivation from a common, pre-malignant precursor. Most mutations were restricted to one or the other of these lymphomas, likely explaining how distinct lymphomas developed from a common ancestral B cell. In the two B-cell/T-cell lymphoma cases, and a composite clonally unrelated HL/chronic lymphocytic leukemia, the lymphoma partners did not share any somatic mutations. In three cases, we identified potentially oncogenic variants also in cells serving as constitutional controls. These variants may have contributed to development of a composite lymphoma/leukemia. We provide additional evidence of frequent clonal relation in composite lymphomas, highlight the multistep transformation process of related lymphomas with a likely pre-malignant intermediate common precursor, and support the importance of constitutional variants in lymphomagenesis.
当一名患者同时或先后发生两种淋巴瘤时,它们是源自同一淋巴细胞或造血前体细胞还是独立发生,这是一个重要问题。我们通过全外显子组测序(WES)研究了四例复合性经典霍奇金淋巴瘤(HL)与其他成熟B细胞淋巴瘤,以及两例复合性成熟B细胞和T细胞肿瘤。对其IGV基因的分析显示,三例复合性B细胞淋巴瘤源自共同经历生发中心的B细胞。WES在这些克隆相关的复合性淋巴瘤的淋巴瘤中鉴定出共享的体细胞突变,表明它们源自共同的癌前前体。大多数突变局限于其中一种或另一种淋巴瘤,这可能解释了不同淋巴瘤如何从共同的祖先B细胞发展而来。在两例B细胞/T细胞淋巴瘤病例以及一例复合性克隆无关的HL/慢性淋巴细胞白血病中,淋巴瘤伙伴未共享任何体细胞突变。在三例病例中,我们在用作体质对照的细胞中也鉴定出潜在的致癌变体。这些变体可能促成了复合性淋巴瘤/白血病的发生。我们提供了复合性淋巴瘤中频繁克隆关系的额外证据,强调了相关淋巴瘤多步骤转化过程,其中可能存在癌前中间共同前体,并支持了体质变体在淋巴瘤发生中的重要性。